The role of hepatitis C virus (HCV) infection in fulminant hepatic failure is controversial. The frequency of serum HCV RNA positivity in previously reported patients with fulminant hepatic failure (FHF) of indeterminate cause ranged from 0 to 12% in the United States and Europe and from 43% to 59%
Cutaneous vasculitis in a patient infected with hepatitis C virus. Detection of hepatitis C virus RNA in the skin by polymerase chain reaction
β Scribed by J.M. Durand; G Kaplanski; M.A. Richard; P. Lefevre; N. Quiles; C. Trepo; J. Soubeyrand
- Book ID
- 108664326
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 692 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The mean prevalence of antiβhepatitis C virus (HCV) in Italy is 0.87%. It reaches 2% in Campania, Southern Italy. Approximately 50% of community acquired nonβA, nonβB (NANB) hepatitis cannot be associated with known parenteral exposure. A recent Italian study has shown that the only dem
The combination of reverse transcription and polymerase chain reaction is a very powerful tool for the detection of hepatitis C virus RNA in sera of patients with hepatitis C virus infection. However, when studying the presence of this virus in tissue using polymerase chain reaction, it may be diffi
Three PCR methods based on the GB virus-C/ hepatitis G virus (GBV-C/HGV) 5ΠUTR and NS3 genomic region were used for the detection of GBV-C/HGV RNA in serum of 62 patients with chronic hepatitis C virus (HCV) infection. Ten of 62 (16%) patients were found to have GBV-C/ HGV RNA, which was confirmed b
## Abstract The low specificity of screening ELISAs for antibodies to hepatitis C virus in blood donors has called for confirmatory tests. Two types of supplementary antibody assays are available, recombinant immunoblot assays (RIBAβ1 and RIBAβ2) and an antibody consumption test referred to as a ne